首页 | 本学科首页   官方微博 | 高级检索  
     

Hs-TSH维持水平与ATD治疗Graves病甲亢预后的关系
引用本文:王少波,周善存,梁志丽. Hs-TSH维持水平与ATD治疗Graves病甲亢预后的关系[J]. 国际医药卫生导报, 2011, 17(3): 281-283. DOI: 10.3760/cma.j.issn.1007-1245.2011.03.010
作者姓名:王少波  周善存  梁志丽
作者单位:王少波 (广东医学院附属厚街医院内分泌科,东莞,523945) ; 周善存 (广东医学院附属厚街医院内分泌科,东莞,523945) ; 梁志丽 (广东医学院附属厚街医院内分泌科,东莞,523945) ;
摘    要:
目的 分析Hs-TSH维持水平与ATD治疗Graves病甲亢预后的关系.方法 对ATD治疗136例Graves病进行了回顾性分析,观察停药1年、2年及3年甲亢的复发率,分析Hs-TSH维持水平与复发率的关系.结果 ATD治疗停药后1年,甲亢的复发率分别是:TSH减低组15.3%,TSH正常组3.5%,TSH增高组1.3...

关 键 词:Graves病  抗甲状腺药物  高敏促甲状腺激素

The relationship of the Hs-TSH and prognosis of GD with ATD
WANG Shao-bo,ZHOU Shan-cun,LIANG Zhi-li. The relationship of the Hs-TSH and prognosis of GD with ATD[J]. International Medicine & Health Guidance News, 2011, 17(3): 281-283. DOI: 10.3760/cma.j.issn.1007-1245.2011.03.010
Authors:WANG Shao-bo  ZHOU Shan-cun  LIANG Zhi-li
Affiliation:( The affihated Houjie Hospital of Guangdong Medical College, Dongguan 523945, China)
Abstract:
Objective To observe the relationship of the Hs-TSH and prognosis of GD with ATD. Methods 136 GD patients with ATD were retrospectively analyzed. The rate of recurrence were comppared after treatment 1 year, 2 year and 3 year. To observe the relationship of the Hs-TSH and recurrence of GD with ATD. Results The rate of recurrence is 15.3%, 3.5% and 1.3% after treatment 1year in TSH decreasing group, TSH normal group and TSH increasing group, Compared the there grous were statistically significant (P< 0.01). The rate of recurrence is same in TSH normal group and TSH increasing group after treatment 3 year, whitch is lower than the TSH decreasing group (P<0.05).Conclusions Hs-TSH can be regarded an index to judge the prognosis treated with ATD.
Keywords:Graves  ATD  Hs-TSH
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号